Due to the discrepancies between the association of the PIP function as pro-cancerous and the mechanism of PIP regulation, we decided to verify the relations between the levels of SOCS3 and PIAS3 inhibitors and the PIP expression in BC cells. The gene discussed is PIAS3; the disease is breast cancer.